156 related articles for article (PubMed ID: 27826541)
21. Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant.
Beljanski V; Chiang C; Kirchenbaum GA; Olagnier D; Bloom CE; Wong T; Haddad EK; Trautmann L; Ross TM; Hiscott J
J Virol; 2015 Oct; 89(20):10612-24. PubMed ID: 26269188
[TBL] [Abstract][Full Text] [Related]
22. Identification and characterisation of a novel anti-viral peptide against avian influenza virus H9N2.
Rajik M; Jahanshiri F; Omar AR; Ideris A; Hassan SS; Yusoff K
Virol J; 2009 Jun; 6():74. PubMed ID: 19497129
[TBL] [Abstract][Full Text] [Related]
23. Crosstalk between H9N2 avian influenza virus and crypt-derived intestinal organoids.
Huang L; Hou Q; Ye L; Yang Q; Yu Q
Vet Res; 2017 Nov; 48(1):71. PubMed ID: 29096712
[TBL] [Abstract][Full Text] [Related]
24. β-Glucans from
Shi S; Yin L; Shen X; Dai Y; Wang J; Yin D; Zhang D; Pan X
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215831
[No Abstract] [Full Text] [Related]
25. Avian Influenza Virus Subtype H9N2 Affects Intestinal Microbiota, Barrier Structure Injury, and Inflammatory Intestinal Disease in the Chicken Ileum.
Li H; Liu X; Chen F; Zuo K; Wu C; Yan Y; Chen W; Lin W; Xie Q
Viruses; 2018 May; 10(5):. PubMed ID: 29783653
[TBL] [Abstract][Full Text] [Related]
26. Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses.
Govorkova EA; Leneva IA; Goloubeva OG; Bush K; Webster RG
Antimicrob Agents Chemother; 2001 Oct; 45(10):2723-32. PubMed ID: 11557461
[TBL] [Abstract][Full Text] [Related]
27. Cross-protective efficacy of dendritic cells targeting conserved influenza virus antigen expressed by Lactobacillus plantarum.
Yang WT; Shi SH; Yang GL; Jiang YL; Zhao L; Li Y; Wang CF
Sci Rep; 2016 Dec; 6():39665. PubMed ID: 28004787
[TBL] [Abstract][Full Text] [Related]
28. Construction of recombinant Marek's disease virus (MDV) lacking the meq oncogene and co-expressing AIV-H9N2 HA and NA genes under control of exogenous promoters.
Zhang Z; Chen W; Ma C; Zhao P; Duan L; Zhang F; Sun A; Li Y; Su H; Li S; Cui H; Cui Z
J Biotechnol; 2014 Jul; 181():45-54. PubMed ID: 24709399
[TBL] [Abstract][Full Text] [Related]
29. Oral administration of live attenuated Salmonella enterica serovar Typhimurium expressing chicken interferon-α alleviates clinical signs caused by respiratory infection with avian influenza virus H9N2.
Rahman MM; Uyangaa E; Han YW; Kim SB; Kim JH; Choi JY; Yoo DJ; Hong JT; Han SB; Kim B; Kim K; Eo SK
Vet Microbiol; 2011 Dec; 154(1-2):140-51. PubMed ID: 21764226
[TBL] [Abstract][Full Text] [Related]
30. Effective small interfering RNAs targeting matrix and nucleocapsid protein gene inhibit influenza A virus replication in cells and mice.
Zhou H; Jin M; Yu Z; Xu X; Peng Y; Wu H; Liu J; Liu H; Cao S; Chen H
Antiviral Res; 2007 Nov; 76(2):186-93. PubMed ID: 17719657
[TBL] [Abstract][Full Text] [Related]
31. Antiviral activity of diallyl trisulfide against H9N2 avian influenza virus infection in vitro and in vivo.
Ming L; Li Z; Li X; Tang L; He G
Virol J; 2021 Aug; 18(1):171. PubMed ID: 34412671
[TBL] [Abstract][Full Text] [Related]
32. Mesenchymal stromal cell treatment prevents H9N2 avian influenza virus-induced acute lung injury in mice.
Li Y; Xu J; Shi W; Chen C; Shao Y; Zhu L; Lu W; Han X
Stem Cell Res Ther; 2016 Oct; 7(1):159. PubMed ID: 27793190
[TBL] [Abstract][Full Text] [Related]
33. Inactivation and morphological changes of avian influenza virus by copper ions.
Horie M; Ogawa H; Yoshida Y; Yamada K; Hara A; Ozawa K; Matsuda S; Mizota C; Tani M; Yamamoto Y; Yamada M; Nakamura K; Imai K
Arch Virol; 2008; 153(8):1467-72. PubMed ID: 18592130
[TBL] [Abstract][Full Text] [Related]
34. Human intestinal epithelial cells are susceptible to influenza virus subtype H9N2.
Qu B; Li X; Gao W; Sun W; Jin Y; Cardona CJ; Xing Z
Virus Res; 2012 Jan; 163(1):151-9. PubMed ID: 21986059
[TBL] [Abstract][Full Text] [Related]
35. Apoptosis induction and release of inflammatory cytokines in the oviduct of egg-laying hens experimentally infected with H9N2 avian influenza virus.
Wang J; Tang C; Wang Q; Li R; Chen Z; Han X; Wang J; Xu X
Vet Microbiol; 2015 Jun; 177(3-4):302-14. PubMed ID: 25911114
[TBL] [Abstract][Full Text] [Related]
36. IPS-1 is essential for type III IFN production by hepatocytes and dendritic cells in response to hepatitis C virus infection.
Okamoto M; Oshiumi H; Azuma M; Kato N; Matsumoto M; Seya T
J Immunol; 2014 Mar; 192(6):2770-7. PubMed ID: 24532585
[TBL] [Abstract][Full Text] [Related]
37. Dynamic analysis of expression of chemokine and cytokine gene responses to H5N1 and H9N2 avian influenza viruses in DF-1 cells.
Luo C; Liu J; Qi W; Ren X; Lu R; Liao M; Ning Z
Microbiol Immunol; 2018 May; 62(5):327-340. PubMed ID: 29577370
[TBL] [Abstract][Full Text] [Related]
38. Oxymatrine Modulation of TLR3 Signaling: A Dual-Action Mechanism for H9N2 Avian Influenza Virus Defense and Immune Regulation.
Zhi Y; Zhao X; Liu Z; Shen G; Zhang T; Zhang T; Hu G
Molecules; 2024 Apr; 29(9):. PubMed ID: 38731436
[TBL] [Abstract][Full Text] [Related]
39. Induction profiles of mRNA of toll like receptors and cytokines in chickens pre-exposed to low pathogenic avian influenza H9N2 virus followed by challenge with highly pathogenic avian influenza H5N1 virus.
Dash SK; Kumar M; Kataria JM; Nagarajan S; Tosh C; Murugkar HV; Rajukumar K; Kalaiyarasu S; Senthil Kumar D; Kulkarni DD
Microb Pathog; 2018 Apr; 117():200-205. PubMed ID: 29476788
[TBL] [Abstract][Full Text] [Related]
40. Molecular identification and comparative transcriptional analysis of myxovirus resistance GTPase (Mx) gene in goose (Anser cygnoide) after H9N2 AIV infection.
Zeng M; Chen S; Wang M; Jia R; Zhu D; Liu M; Sun K; Yang Q; Wu Y; Chen X; Cheng A
Comp Immunol Microbiol Infect Dis; 2016 Aug; 47():32-40. PubMed ID: 27477505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
